Live Breaking News & Updates on Provider Relief Fund Program
Stay updated with breaking news from Provider relief fund program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently conducted two audits of HHS management of healthcare provider loan and funding programs. ....
(Photo by Alexandru Pavalache.EyeEm\Getty Images) The Department of Health and Human Services, through the Health Resources and Services Administration, has announced a new program for providers to cover the cost of administering COVID-19 vaccines to patients enrolled in health plans that either do not cover vaccination fees or cover them with patient cost-sharing. The COVID-19 Coverage Assistance Fund addresses a provider need to be reimbursed for uncompensated costs. Providers cannot bill patients for COVID-19 vaccination fees. HHS Secretary Xavier Becerra said, We listened to our healthcare providers on the frontlines of the pandemic. On top of increasing reimbursement rates tied to administering the shots, we are closing the final payment gap that resulted as vaccines were administered to underinsured individuals. No healthcare provider should hesitate to deliver these critical vaccines to patients over reimbursement cost concerns. ....
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, CMS issued several rules, while President-elect Biden announced the framework for his COVID-19 relief plan. Read more about these actions and other news below. I. Regulations, Notices & Guidance On January 12, 2021, the Centers for Medicare & Medicaid Services (CMS) issued a final rule entitled, Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary.” This final rule establishes a Medicare coverage pathway to provide Medicare beneficiaries nationwide with faster access to new, innovative medical devices designated as breakthrough by the Food and Drug Administration (FDA). The Medicare Coverage of Innov ....